Long‐Term Effect of 2 Years of Persistent Guselkumab Therapy on Disease Severity and Patient‐Reported Outcomes in the CorEvitas Psoriasis Registry
- DOI
- 10.1155/dth/7233752
- Published
- 2026-01
- Container
- Dermatologic Therapy
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1155/dth/7233752,
title = {Long‐Term Effect of 2 Years of Persistent Guselkumab Therapy on Disease Severity and Patient‐Reported Outcomes in the CorEvitas Psoriasis Registry},
author = {Bruce E. Strober and April W. Armstrong and Timothy Fitzgerald and Katelyn Rowland and Olivia Choi and Daphne Chan and Jud C. Janak and Maya Marchese and Rachel E. Teneralli and Hyung-Joo Kang and Alvin H. Li and Steven R. Feldman},
year = {2026},
journal = {Dermatologic Therapy},
doi = {10.1155/dth/7233752},
url = {https://doi.org/10.1155/dth/7233752}
}RIS
TY - JOUR TI - Long‐Term Effect of 2 Years of Persistent Guselkumab Therapy on Disease Severity and Patient‐Reported Outcomes in the CorEvitas Psoriasis Registry AU - Bruce E. Strober AU - April W. Armstrong AU - Timothy Fitzgerald AU - Katelyn Rowland AU - Olivia Choi AU - Daphne Chan AU - Jud C. Janak AU - Maya Marchese AU - Rachel E. Teneralli AU - Hyung-Joo Kang AU - Alvin H. Li AU - Steven R. Feldman PY - 2026 JO - Dermatologic Therapy DO - 10.1155/dth/7233752 UR - https://doi.org/10.1155/dth/7233752 ER -
APA
Strober, B. E., Armstrong, A. W., Fitzgerald, T., Rowland, K., Choi, O., Chan, D., Janak, J. C., Marchese, M., Teneralli, R. E., Kang, H., Li, A. H., & Feldman, S. R. (2026). Long‐Term Effect of 2 Years of Persistent Guselkumab Therapy on Disease Severity and Patient‐Reported Outcomes in the CorEvitas Psoriasis Registry. Dermatologic Therapy. https://doi.org/10.1155/dth/7233752
Source records
- crossref · retrieved 2026-09-25T00:54:54.053Z